Clorazepate Dipotassium

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 72603-112
  • Package NDC 72603-112-01
  • Package NDC 72603-112-02
  • Application number ANDA075731
  • SPL ID 258be954-8e31-2be4-e063-6394a90a78ca
  • SPL set ID fb5c9e98-02b2-4c36-b436-25b58fe3c7d5
  • UNII 63FN7G03XY
  • RxCUI 197464
  • RxCUI 197465
  • RxCUI 197466

What the source publishes

Labeler
NORTHSTAR RX LLC
Active ingredients
Clorazepate Dipotassium
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:72603-112_258be954-8e31-2be4-e063-6394a90a78ca
{
  "name": "Clorazepate Dipotassium",
  "splId": "258be954-8e31-2be4-e063-6394a90a78ca",
  "labels": [
    {
      "setId": "fb5c9e98-02b2-4c36-b436-25b58fe3c7d5",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fb5c9e98-02b2-4c36-b436-25b58fe3c7d5",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fb5c9e98-02b2-4c36-b436-25b58fe3c7d5"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "NORTHSTAR RX LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "100 TABLET in 1 BOTTLE (72603-112-01)",
      "package_ndc": "72603-112-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20221024"
    },
    {
      "sample": false,
      "description": "500 TABLET in 1 BOTTLE (72603-112-02)",
      "package_ndc": "72603-112-02",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20221024"
    }
  ],
  "productId": "72603-112_258be954-8e31-2be4-e063-6394a90a78ca",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "72603-112",
  "deaSchedule": "CIV",
  "genericName": "Clorazepate Dipotassium",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "CLORAZEPATE DIPOTASSIUM",
      "strength": "3.75 mg/1"
    }
  ],
  "applicationNumber": "ANDA075731",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20221024",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "63FN7G03XY"
    ],
    "rxcui": [
      "197464",
      "197465",
      "197466"
    ],
    "spl_set_id": [
      "fb5c9e98-02b2-4c36-b436-25b58fe3c7d5"
    ],
    "manufacturer_name": [
      "NORTHSTAR RX LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:72603-112_258be954-8e31-2be4-e063-6394a90a78ca"